BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 37480063)

  • 21. Critical assessment of chitotriosidase analysis in the rational laboratory diagnosis of children with Gaucher disease and Niemann-Pick disease type A/B and C.
    Ries M; Schaefer E; Lührs T; Mani L; Kuhn J; Vanier MT; Krummenauer F; Gal A; Beck M; Mengel E
    J Inherit Metab Dis; 2006 Oct; 29(5):647-52. PubMed ID: 16972172
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glycoprotein non-metastatic protein B (GPNMB) plasma values in patients with chronic visceral acid sphingomyelinase deficiency.
    Eskes ECB; van der Lienden MJC; Sjouke B; van Vliet L; Brands MMMG; Hollak CEM; Aerts JMFG
    Mol Genet Metab; 2023 Aug; 139(4):107631. PubMed ID: 37453187
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cut-off values of neonatal lysosomal storage disease-related enzymes detected by tandem mass spectrometry.
    Li G; Tian L; Guo Y; Li Y; Sun M; Zou H
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2022 Jun; 51(3):321-325. PubMed ID: 35462462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Newborn screening for six lysosomal storage disorders in a cohort of Mexican patients: Three-year findings from a screening program in a closed Mexican health system.
    Navarrete-Martínez JI; Limón-Rojas AE; Gaytán-García MJ; Reyna-Figueroa J; Wakida-Kusunoki G; Delgado-Calvillo MDR; Cantú-Reyna C; Cruz-Camino H; Cervantes-Barragán DE
    Mol Genet Metab; 2017 May; 121(1):16-21. PubMed ID: 28302345
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of tandem mass spectrometry for newborn screening of 6 lysosomal storage disorders in a Korean population.
    Han M; Jun SH; Song SH; Park KU; Kim JQ; Song J
    Korean J Lab Med; 2011 Oct; 31(4):250-6. PubMed ID: 22016678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Newborn screening for lysosomal storage disorders.
    Matern D; Gavrilov D; Oglesbee D; Raymond K; Rinaldo P; Tortorelli S
    Semin Perinatol; 2015 Apr; 39(3):206-16. PubMed ID: 25891428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. AISF update on the diagnosis and management of adult-onset lysosomal storage diseases with hepatic involvement.
    Nascimbeni F; Dionisi Vici C; Vespasiani Gentilucci U; Angelico F; Nobili V; Petta S; Valenti L;
    Dig Liver Dis; 2020 Apr; 52(4):359-367. PubMed ID: 31902560
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Utility of amniotic fluid chitotriosidase in the prenatal diagnosis of lysosomal storage disorders.
    Kadali S; Madalasa T; Reddy GM; Naushad SM
    Clin Biochem; 2018 Nov; 61():40-44. PubMed ID: 30205089
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Short-incubation mass spectrometry assay for lysosomal storage disorders in newborn and high-risk population screening.
    Mechtler TP; Metz TF; Müller HG; Ostermann K; Ratschmann R; De Jesus VR; Shushan B; Di Bussolo JM; Herman JL; Herkner KR; Kasper DC
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Nov; 908():9-17. PubMed ID: 23122395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tandem mass spectrometry-based multiplex assays for α-mannosidosis and fucosidosis.
    Kumar AB; Hong X; Yi F; Wood T; Gelb MH
    Mol Genet Metab; 2019 Jul; 127(3):207-211. PubMed ID: 31235216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cause of death in patients with chronic visceral and chronic neurovisceral acid sphingomyelinase deficiency (Niemann-Pick disease type B and B variant): Literature review and report of new cases.
    Cassiman D; Packman S; Bembi B; Turkia HB; Al-Sayed M; Schiff M; Imrie J; Mabe P; Takahashi T; Mengel KE; Giugliani R; Cox GF
    Mol Genet Metab; 2016 Jul; 118(3):206-213. PubMed ID: 27198631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contribution of tandem mass spectrometry to the diagnosis of lysosomal storage disorders.
    Piraud M; Pettazzoni M; Lavoie P; Ruet S; Pagan C; Cheillan D; Latour P; Vianey-Saban C; Auray-Blais C; Froissart R
    J Inherit Metab Dis; 2018 May; 41(3):457-477. PubMed ID: 29556840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lysosomal storage disorder screening implementation: findings from the first six months of full population pilot testing in Missouri.
    Hopkins PV; Campbell C; Klug T; Rogers S; Raburn-Miller J; Kiesling J
    J Pediatr; 2015 Jan; 166(1):172-7. PubMed ID: 25444528
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Direct multiplex assay of lysosomal enzymes in dried blood spots for newborn screening.
    Li Y; Scott CR; Chamoles NA; Ghavami A; Pinto BM; Turecek F; Gelb MH
    Clin Chem; 2004 Oct; 50(10):1785-96. PubMed ID: 15292070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simultaneous Testing for 6 Lysosomal Storage Disorders and X-Adrenoleukodystrophy in Dried Blood Spots by Tandem Mass Spectrometry.
    Tortorelli S; Turgeon CT; Gavrilov DK; Oglesbee D; Raymond KM; Rinaldo P; Matern D
    Clin Chem; 2016 Sep; 62(9):1248-54. PubMed ID: 27440509
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A column-switching HPLC-MS/MS method for mucopolysaccharidosis type I analysis in a multiplex assay for the simultaneous newborn screening of six lysosomal storage disorders.
    Gucciardi A; Legnini E; Di Gangi IM; Corbetta C; Tomanin R; Scarpa M; Giordano G
    Biomed Chromatogr; 2014 Aug; 28(8):1131-9. PubMed ID: 24449175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma and dried blood spot lysosphingolipids for the diagnosis of different sphingolipidoses: a comparative study.
    Polo G; Burlina AP; Ranieri E; Colucci F; Rubert L; Pascarella A; Duro G; Tummolo A; Padoan A; Plebani M; Burlina AB
    Clin Chem Lab Med; 2019 Nov; 57(12):1863-1874. PubMed ID: 31091195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Consensus recommendation for a diagnostic guideline for acid sphingomyelinase deficiency.
    McGovern MM; Dionisi-Vici C; Giugliani R; Hwu P; Lidove O; Lukacs Z; Eugen Mengel K; Mistry PK; Schuchman EH; Wasserstein MP
    Genet Med; 2017 Sep; 19(9):967-974. PubMed ID: 28406489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum protein profile analysis in lysosomal storage disorders patients.
    López de Frutos L; García-González E; García-Rodríguez B; González-Irazabal Y; Lahoz C; Irún P; Cebolla JJ; Giraldo P
    Clin Chim Acta; 2020 Nov; 510():430-436. PubMed ID: 32745579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical relevance of endpoints in clinical trials for acid sphingomyelinase deficiency enzyme replacement therapy.
    Jones SA; McGovern M; Lidove O; Giugliani R; Mistry PK; Dionisi-Vici C; Munoz-Rojas MV; Nalysnyk L; Schecter AD; Wasserstein M
    Mol Genet Metab; 2020; 131(1-2):116-123. PubMed ID: 32616389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.